Chemoinformaics analysis of CANTONIENSISTRIOL
| Molecular Weight | 458.727 | nRot | 0 |
| Heavy Atom Molecular Weight | 408.327 | nRig | 26 |
| Exact Molecular Weight | 458.376 | nRing | 5 |
| Solubility: LogS | -3.598 | nHRing | 0 |
| Solubility: LogP | 5.695 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 83 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 85.8456 |
| nHD | 3 | BPOL | 50.1604 |
| QED | 0.384 |
| Synth | 4.898 |
| Natural Product Likeliness | 3.16 |
| NR-PPAR-gamma | 0.493 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.376 |
| Pgp-sub | 0.001 |
| HIA | 0.021 |
| CACO-2 | -4.868 |
| MDCK | 0.0000109 |
| BBB | 0.926 |
| PPB | 0.973681 |
| VDSS | 1.047 |
| FU | 0.0418847 |
| CYP1A2-inh | 0.008 |
| CYP1A2-sub | 0.164 |
| CYP2c19-inh | 0.021 |
| CYP2c19-sub | 0.942 |
| CYP2c9-inh | 0.097 |
| CYP2c9-sub | 0.378 |
| CYP2d6-inh | 0.016 |
| CYP2d6-sub | 0.574 |
| CYP3a4-inh | 0.106 |
| CYP3a4-sub | 0.321 |
| CL | 16.505 |
| T12 | 0.017 |
| hERG | 0.003 |
| Ames | 0.023 |
| ROA | 0.11 |
| SkinSen | 0.022 |
| Carcinogencity | 0.012 |
| EI | 0.031 |
| Respiratory | 0.971 |
| NR-Aromatase | 0.718 |
| Antiviral | No |
| Prediction | 0.652883 |